83 related articles for article (PubMed ID: 8088309)
21. Growth hormone and IGF-I in diabetic children with and without microalbuminuria.
Verrotti A; Cieri F; Petitti MT; Morgese G; Chiarelli F
Diabetes Nutr Metab; 1999 Aug; 12(4):271-6. PubMed ID: 10782753
[TBL] [Abstract][Full Text] [Related]
22. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
[TBL] [Abstract][Full Text] [Related]
23. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
Nosadini R; Brocco E
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
[TBL] [Abstract][Full Text] [Related]
24. Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study.
Voulgari C; Katsilambros N; Tentolouris N
Metabolism; 2011 Oct; 60(10):1456-64. PubMed ID: 21489578
[TBL] [Abstract][Full Text] [Related]
25. Functional subtypes of renal alpha1-adrenoceptor in spontaneously hypertensive rats with streptozotocin-induced experimental diabetic nephropathy.
Khan MA; Sattar MA; Abdullah NA; Abdulla MH; Salman IM; Kazi RN; Swarup KR; Rathore HA; Basri F; Hussain NM; Dewa A; Johns EJ
Kidney Blood Press Res; 2009; 32(5):349-59. PubMed ID: 19844130
[TBL] [Abstract][Full Text] [Related]
26. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1997 Jul; 44(1):61-8. PubMed ID: 9241098
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
[TBL] [Abstract][Full Text] [Related]
28. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
[TBL] [Abstract][Full Text] [Related]
29. Cigarette smoking in men and vascular responsiveness.
Butler R; Morris AD; Struthers AD
Br J Clin Pharmacol; 2001 Aug; 52(2):145-9. PubMed ID: 11488770
[TBL] [Abstract][Full Text] [Related]
30. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
Romanelli G; Giustina A; Bossoni S; Caldonazzo A; Cimino A; Cravarezza P; Giustina G
Diabetes; 1990 Nov; 39(11):1333-8. PubMed ID: 2227107
[TBL] [Abstract][Full Text] [Related]
31. Abnormal albuminuria and blood pressure rise in incipient diabetic nephropathy induced by exercise.
Christensen CK
Kidney Int; 1984 May; 25(5):819-23. PubMed ID: 6471668
[TBL] [Abstract][Full Text] [Related]
32. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms.
Nosadini R; Velussi M; Brocco E; Abaterusso C; Piarulli F; Morgia G; Satta A; Faedda R; Abhyankar A; Luthman H; Tonolo G
Diabetes; 2005 Jan; 54(1):228-33. PubMed ID: 15616033
[TBL] [Abstract][Full Text] [Related]
33. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
34. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.
Ellis D; Forrest KY; Erbey J; Orchard TJ
Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367
[TBL] [Abstract][Full Text] [Related]
35. Smoking and progression of diabetic nephropathy in type 1 diabetes.
Hovind P; Rossing P; Tarnow L; Parving HH
Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
[TBL] [Abstract][Full Text] [Related]
36. Noradrenaline-induced vasoconstriction in the uterine vascular bed of pregnant rats chronically treated with L-NAME: role of prostanoids.
Yousif MH; Chandrasekhar B; Kadavil EA; Oriowo MA
J Cardiovasc Pharmacol; 2003 Sep; 42(3):428-35. PubMed ID: 12960689
[TBL] [Abstract][Full Text] [Related]
37. Glomerular hyperfiltration in microalbuminuric NIDDM patients.
Vedel P; Obel J; Nielsen FS; Bang LE; Svendsen TL; Pedersen OB; Parving HH
Diabetologia; 1996 Dec; 39(12):1584-9. PubMed ID: 8960846
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
Gall MA; Hougaard P; Borch-Johnsen K; Parving HH
BMJ; 1997 Mar; 314(7083):783-8. PubMed ID: 9080995
[TBL] [Abstract][Full Text] [Related]
39. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
[TBL] [Abstract][Full Text] [Related]
40. Insulin-induced attenuation of noradrenaline-mediated vasoconstriction in resistance arteries from Wistar rats is nitric oxide dependent.
Walker AB; Savage MW; Dores J; Williams G
Clin Sci (Lond); 1997 Feb; 92(2):147-52. PubMed ID: 9059315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
